These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 16553825

  • 21. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
    Marcinkiewicz J, Biedroń R, Białecka A, Kasprowicz A, Mak M, Targosz M.
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):61-8. PubMed ID: 16642259
    [Abstract] [Full Text] [Related]

  • 22. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
    Sugisaki H, Yamanaka K, Kakeda M, Kitagawa H, Tanaka K, Watanabe K, Gabazza EC, Kurokawa I, Mizutani H.
    J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
    [Abstract] [Full Text] [Related]

  • 23. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.
    Leyden JJ, Del Rosso JQ, Webster GF.
    Dermatol Clin; 2009 Jan; 27(1):1-15. PubMed ID: 18984363
    [Abstract] [Full Text] [Related]

  • 24. Inflammation in rosacea and acne: Implications for patient care.
    Fleischer AB.
    J Drugs Dermatol; 2011 Jun; 10(6):614-20. PubMed ID: 21961194
    [Abstract] [Full Text] [Related]

  • 25. [Is acne caused by colonization with the "wrong" strain of Propionibacterium acnes? A review of the role of Propionibacterium acnes in acne].
    Lomholt HB, Kilian M.
    Ugeskr Laeger; 2008 Apr 07; 170(15):1234-7. PubMed ID: 18433578
    [Abstract] [Full Text] [Related]

  • 26. The potential use of Echinacea in acne: control of Propionibacterium acnes growth and inflammation.
    Sharma M, Schoop R, Suter A, Hudson JB.
    Phytother Res; 2011 Apr 07; 25(4):517-21. PubMed ID: 20830697
    [Abstract] [Full Text] [Related]

  • 27. In vitro evaluation of antibacterial activities and anti-inflammatory effects of Bifidobacterium spp. addressing acne vulgaris.
    Lee DK, Kim MJ, Ham JW, An HM, Cha MK, Lee SW, Park CI, Shin SH, Lee KO, Kim KJ, Ha NJ.
    Arch Pharm Res; 2012 Jun 07; 35(6):1065-71. PubMed ID: 22870816
    [Abstract] [Full Text] [Related]

  • 28. Re-evaluating treatment targets in acne vulgaris: adapting to a new understanding of pathophysiology.
    Kircik LH.
    J Drugs Dermatol; 2014 Jun 07; 13(6):s57-60. PubMed ID: 24918572
    [Abstract] [Full Text] [Related]

  • 29. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A, Sangal L, Basal E, Kaushal GP, Agarwal SK.
    Dermatol Online J; 2002 Oct 07; 8(2):2. PubMed ID: 12546757
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The potential immunomodulatory effects of topical retinoids.
    Jones DA.
    Dermatol Online J; 2005 Mar 01; 11(1):3. PubMed ID: 15748544
    [Abstract] [Full Text] [Related]

  • 32. Novel pharmacological approaches for the treatment of acne vulgaris.
    Valente Duarte de Sousa IC.
    Expert Opin Investig Drugs; 2014 Oct 01; 23(10):1389-410. PubMed ID: 24890096
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bactericidal cationic peptides can also function as bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is enigmatic why this concept is consistently disregarded.
    Ginsburg I.
    Med Hypotheses; 2004 Oct 01; 62(3):367-74. PubMed ID: 14975505
    [Abstract] [Full Text] [Related]

  • 35. Potential therapeutic application of host defense peptides.
    Zhang L, Falla TJ.
    Methods Mol Biol; 2010 Oct 01; 618():303-27. PubMed ID: 20094872
    [Abstract] [Full Text] [Related]

  • 36. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
    Fakhouri T, Yentzer BA, Feldman SR.
    J Drugs Dermatol; 2009 Jul 01; 8(7):657-61. PubMed ID: 19588642
    [Abstract] [Full Text] [Related]

  • 37. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W, Martínez MA, Molina MT, Zapata S, Valenzuela ME.
    Rev Latinoam Microbiol; 2006 Jul 01; 48(1):14-6. PubMed ID: 17357569
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [The influence of AMPs from HaCaT keratinocytes on some bacteria strains derived from skin changes].
    Wiechuła B, Wilk I, Ekiel A, Tustanowski J, Martirosian G.
    Med Dosw Mikrobiol; 2006 Jul 01; 58(2):163-8. PubMed ID: 17133910
    [Abstract] [Full Text] [Related]

  • 40. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity.
    Nan YH, Bang JK, Shin SY.
    Peptides; 2009 May 01; 30(5):832-8. PubMed ID: 19428758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.